Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) — The “Cell Therapy Human Raw Materials Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.
The Cell Therapy Human Raw Materials Market was valued at USD 2.68 Billion in 2024, and is expected to reach USD 5.43 Billion by 2030, rising at a CAGR of 12.43%. The Global Cell Therapy Human Raw Materials Market is experiencing significant growth as the field of cell therapy continues to advance, offering innovative solutions for various diseases and medical conditions.
The rise in cell therapy research and development, coupled with increasing clinical applications, is driving the demand for high-quality and reliable human raw materials. Stem cells, in particular, are gaining prominence in cell therapy, contributing to the expansion of this market. The versatility of stem cells and their potential to differentiate into various cell types make them key components in the production of cell-based therapies.
As the cell therapy landscape evolves, there is a growing emphasis on optimizing manufacturing processes and ensuring the scalability of production. This underscores the importance of sourcing standardized and well-characterized human raw materials to meet the regulatory requirements and quality standards necessary for successful cell therapy development. Collaborations and partnerships between cell therapy companies and raw material suppliers are becoming more prevalent, fostering innovation and ensuring a stable supply chain.
The market also benefits from advancements in bioprocessing technologies, which contribute to the efficient and cost-effective production of cell therapies. While the potential of cell therapy to revolutionize healthcare is substantial, challenges such as scalability, standardization, and regulatory compliance persist. Addressing these challenges requires ongoing collaboration, research, and investment in the development and optimization of human raw materials for cell therapy applications. The Global Cell Therapy Human Raw Materials Market is poised for continued growth as it plays a pivotal role in supporting the expanding landscape of cell-based therapeutic interventions.
Market Drivers
- Rising Demand for Cell Therapies
- Expansion of Clinical Applications
Market Challenges
- Regulatory Hurdles
- Standardization and Quality Control
Market Trends
- Advancements in Stem Cell Therapy
- Increased Emphasis on Clinical Evidence
Based on region, North America is projected to dominate the Global Cell Therapy Human Raw Materials Market over the forecast period. The region possesses a highly developed and sophisticated healthcare infrastructure, facilitating advanced cell therapy research and development. Significant investments in cutting-edge technologies, coupled with extensive research initiatives, contribute to the continuous innovation of human raw materials for cell therapy. Thirdly, the presence of major pharmaceutical and biotechnology companies actively engaged in cell therapy drives market leadership.
A well-defined regulatory framework and strategic collaborations between industry and research institutions foster a conducive environment for market growth. These combined elements position North America at the forefront, establishing its dominance in the global Cell Therapy Human Raw Materials Market.
Key Players Profiled in the Cell Therapy Human Raw Materials Market
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Danaher Corporation
- Sartorius AG
- Aceto Holding GmbH
- Acrobiosystems Inc.
- Grifols, SA
- Charles River Laboratories International, Inc.
- RoosterBio, Inc.
Report Scope
Cell Therapy Human Raw Materials Market, By Product:
- Cell Culture Media
- Cell Culture Sera
- Cell Culture Supplements
- Reagents & Buffers
- Other
Cell Therapy Human Raw Materials Market, By End User:
- Biopharmaceutical & Pharmaceutical Companies
- CROs & CMOs
- Academic & Research Institutions
Cell Therapy Human Raw Materials Market, By Region:
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Key Attributes
Report Attribute | Details |
No. of Pages | 185 |
Forecast Period | 2024-2030 |
Estimated Market Value (USD) in 2024 | $2.68 Billion |
Forecasted Market Value (USD) by 2030 | $5.43 Billion |
Compound Annual Growth Rate | 12.4% |
Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/4vsn52
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Cell Therapy Human Raw Materials Market